OBJECTIVE: Castleman's disease (CD) is a rare disorder of unknown aetiology characterized by lymph node enlargement. This study evaluated the clinical features, diagnosis and outcomes of surgical treatment in patients with CD. METHODS: The medical records of 10 patients with histologically confirmed CD who underwent surgery between 2003 and 2008 were retrospectively reviewed. Study endpoints were survival and recurrence. RESULTS: The age of disease onset ranged from 11 to 63 years (median 38 years). Of the 10 patients included in the study, eight were diagnosed with localized (unicentric) CD and two with multicentric CD. All eight patients with localized (unicentric) CD were asymptomatic. Histological evidence indicated the hyaline vascular form of CD in eight patients and the plasmacytic form in the remaining two patients. The primary treatment was complete surgical resection in nine cases, and these patients were alive with no evidence of recurrence or exacerbation at the time of writing (June 2011). CONCLUSIONS: Localized (unicentric) CD is usually of the hyaline vascular form and complete surgical excision of the tumour allows full recovery in most cases.
Introduction
Castleman's disease (CD), also known as angiofollicular lymph node hyperplasia, is an uncommon lymphoproliferative disorder that encompasses a diverse group of clinical syndromes. 1 Although the exact incidence of CD is unknown, the study of its characteristics is of clinical relevance because of its association with human immunodeficiency virus (HIV) and human herpes virus (HHV)-8 infections. CD is categorized into two clinical types: unicentric or localized, first described by Castleman et al. in 1956, 2 is most commonly of the hyaline vascular form; and multicentric or systemic, which is almost always of the plasmacytic form. 3 The hyaline vascular form is the most common type of CD overall and represents 85 -90% of cases, the plasmacytic form of CD accounts for 10 -15% of cases and a small percentage of patients present with CD of a mixed histological appearance. 4 Patients of any age may be affected by CD and it has been reported from adolescence and into the seventh decade. 4, 5 The disease can occur anywhere along the lymphatic chain, although the majority of cases (70%) occur in the mediastinum. 6 Extrathoracic sites have been reported in the neck, axilla, mesentery, pelvis, pancreas, adrenal gland N Zhou, CW Huang, C Huang et al.
Castleman's disease and retroperitoneum. 4, 7, 8 Diagnosis is often confirmed only after the histological evaluation of surgical specimens, and treatment includes curative surgery for localized CD and chemotherapy for multicentric disease. The present study evaluated, by a retrospective review of medical records, the clinical features, diagnosis and surgical outcomes in patients with histologically confirmed CD.
Patients and methods

STUDY POPULATION AND DATA SOURCE
The medical records of patients with histologically confirmed CD who underwent surgery at Huashan Hospital in Shanghai, China, between January 2003 and December 2008 were retrieved from the hospital pathology database (which included all the surgical patients of Huashan Hospital), using the search term 'Castleman's disease'. The medical records were reviewed for demographic data and for the clinical and pathological characteristics of CD. All patients were followed-up either at the Department of Surgery, Huashan Hospital or by telephone, with the final follow-up assessment carried out at the Department of Surgery, Huashan Hospital in January 2009. Study endpoints included survival and disease recurrence, as assessed by physical examination. The study was approved by the Ethics Committee of Huashan Hospital, Shanghai (Ref. No. E20090115). All patients participating in the study provided written informed consent prior to their participation.
CLASSIFICATION OF CD
Tissue samples obtained during surgical resection were stained with haematoxylin and eosin and used for histopathological classification of CD. The histopathological criteria for diagnosis of the hyaline vascular form of CD included the proliferation of small hyalinized follicular centres with radially arranged capillaries penetrating the germinal centre, and striking proliferation in the interfollicular stroma. The plasmacytic form of CD was diagnosed histopathologically by the presence of lymphoid follicular proliferation with larger follicles and a predominance of mature plasma cells in the interfollicular stroma, which was less vascular than in the hyaline vascular variant. 9 Localized (unicentric) CD was diagnosed if patients presented with histological involvement of only one group of lymph nodes. Multicentric CD was diagnosed in patients presenting with involvement of two or more lymph node groups. Systemic symptoms were attributed to CD if no other cause was found.
Results
The study included all 10 cases of histologically confirmed CD who underwent surgery at Huashan Hospital between January 2003 and December 2008 (median age 38 years, range 11 -63 years). Demographic and clinical data for the patients included in the study are shown in Table 1 .
Localized (unicentric) CD of the hyaline vascular form was diagnosed in eight patients. All of these patients were asymptomatic and enlarged lymph nodes were identified either incidentally or by physical examination. The medical history and laboratory findings of these patients were unremarkable and none had a family history of CD. The primary treatment for these patients was complete surgical resection.
Multicentric CD was diagnosed in two patients, both of whom were symptomatic before surgery. One of these was a 44-yearold woman who presented with abdominal pain and anaemia, and was diagnosed with the plasmacytic (multicentric) form of CD. This patient had generalized peripheral (submaxillary) and abdominal lymphadenopathy but otherwise unremarkable laboratory findings and medical history. She was treated with complete surgical resection. The other patient was a 63-year-old man who presented with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS syndrome), fever, splenomegaly and weight loss. His medical history was unremarkable, but a number of abnormal laboratory results were observed including anaemia, thrombocytopenia, coagulation abnormalities, hyperglycaemia and abnormal liver function tests. The patient also presented with an abdominal mass and was suspected of having a retroperitoneal tumour. Contrastenhanced computed tomography (CT, Fig.  1A ) and positron-emission tomography (PET, Fig. 1B ) images showed an abdominal mass but could not differentiate between CD and malignant disease. Exploratory laparotomy revealed mesenteric lymph nodes of 8 × 8 × 6 cm that were adhering to the mesenteric root and could not be completely resected. A biopsy was taken and the patient was diagnosed with plasmacytic (multicentric) CD. Treatment was with combination chemotherapy using cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP). 10 The postsurgical outcomes of the 10 patients in this study are listed in Table 1 . In the eight cases of localized (unicentric) CD, masses were well demarcated and could be easily separated from adjacent tissues before complete removal. These patients remained asymptomatic following complete resection. The two patients with the plasmacytic (multicentric) form of CD were also asymptomatic after treatment. At the time of writing (June 2011), all 10 patients were alive: nine with no evidence of recurrence or exacerbation of CD, and one with symptoms of CD.
Discussion
Castleman's disease is a very rare disorder of lymphoid tissue that is characterized by lymph node enlargement. The aetiology of CD is unclear although it has been attributed to a hamartomatous process, autoimmune disease, chronic inflammation or immunodeficiency and infection. 11 Although the cause of CD was not determined in the present study, several case series have suggested that it is associated with HHV-8 infection 12 -15 and related to increased levels of interleukin-6 (IL-6). 16 -18 Clinical findings and disease course vary considerably between different types of CD. Unicentric hyaline vascular CD presents equally in men and women 19 and is the most common type of CD, accounting for approximately 85 -90% of cases. Enlarged lymph nodes can be identified either incidentally or through symptoms related to local mass effects, although systemic symptoms are rare. 20 The unicentric plasmacytic form represents approximately 10 -15% of CD cases. 4 Most of the patients included in the present study were asymptomatic, with palpable superficially located solitary lymph nodes. Consistent with the literature, 21 the eight patients diagnosed with unicentric CD did not demonstrate any systemic symptoms.
Multicentric CD is more varied than unicentric disease in its clinical manifestation. Systemic symptoms that can be severe or life threatening are the presenting feature in most cases. A large proportion of patients experience fever, night N Zhou, CW Huang, C Huang et al.
Castleman's disease sweats, weakness, fatigue, anorexia and weight loss. In addition, patients may experience oedema, ascites, pleural or pericardial effusions and skin rashes. 22 The majority of patients with multicentric CD have multifocal lymphadenopathy, with hepatosplenomegaly in > 50% of cases. 19 A range of laboratory abnormalities including thrombocytopenia, elevated erythrocyte sedimentation rate, hypoalbuminuria, 23 Anaemia (anaemia of chronic disease, in particular) or haemolysis are also present in the majority of patients. 24 The clinical course of multicentric CD is variable and may progress over several months or be episodic with recurrent exacerbations over a number of years. 25 Some patients may be largely asymptomatic or have spontaneous abatement of symptoms. A variety of related processes and other diseases have been associated with multicentric CD including HIV infection, Kaposi's sarcoma and non-Hodgkin's lymphoma. 26 CD is also frequently associated with POEMS syndrome and this has been proposed as a minor criterion in its diagnosis. 27 The utility of ultrasonography, CT, magnetic resonance imaging (MRI) and PET scanning have been assessed in CD 28 -31 Imaging findings appear to be related to histological types, although MRI findings seem to be nonspecific. 30 No technique is sufficiently specific to diagnose deeply located lesions on the basis of their appearance. A definitive diagnosis requires an excisional biopsy. 32 This is consistent with the findings of the present study in which CT and PET scanning were unable to differentiate between CD and lymphoma or other malignant disease when applied to the retroperitoneal mass in one patient (24- yearold male) in the present study. In this case, despite failure to resect the abdominal mass completely, surgical biopsy was able to make a definitive diagnosis of CD resulting in an acceptable clinical outcome.
A consistent and systematic approach to the management of patients with CD is confounded by the relative rarity and heterogeneity of the condition. Surgical resection is usually successful in patients with unicentric CD regardless of whether it is the hyaline vascular or plasmacytic form, 5 and may be useful in abdominal masses. 33 Radiation therapy may be an effective alternative to surgical resection in localized disease and has been shown to have response rates of up to 72%. 34 Surgical outcomes for hyaline vascular CD have been reported in six case series comprising 112 patients (Table 2) . 4,10,34 -37 With the addition of the eight patients diagnosed with hyaline vascular CD from the present study the total number of cases investigated reaches 120, three of whom died 36 Symptomatic multicentric CD requires systemic therapy that should be tailored to the patient's needs and overall condition. Asymptomatic multicentric CD is rare and is usually treated without specific intervention. Complete resection, however, can cure CD, as shown in the present study. Steroids will ameliorate symptoms, improve lymphadenopathy and correct laboratory abnormalities, but the effect is generally temporary with recurrence of symptoms likely on tapering or discontinuation of treatment. 38 Long-term steroid use has been associated with an increase in the risk of potentially fatal bacterial infections 39, 40 and may best be reserved for temporary intervention in acute disease. Current practice is to use chemotherapy as the first line therapy in the majority of symptomatic patients. 19 The most commonly reported regimens are cyclophosphamide, vincristine, doxorubicin and dexamethasone (CVAD) and CHOP, both of which have been shown to have mixed success. 20 Response rates of single agent or combination chemotherapy have been estimated to be > 90%, although complete remission rates are considerably lower at < 30%. 5,25,34,41 -44 The pathophysiology of CD provides several further opportunities for therapeutic intervention. Rituximab, a monoclonal antibody to CD20, has been shown to be effective in both HIVpositive and -negative patients with multicentric CD. 45 -48 Tocilizumab (a humanized antihuman IL-6 receptor monoclonal antibody) and targeted agents, such as thalidomide and bortezomib, may also be useful in the pharmacological management of CD. 19 Ganciclovir, interferon-α or rituximab may be the best pharmacological treatment options in patients with CD and concomitant HHV-8 infection, 49 and CHOP may be most appropriate for patients with severe systemic manifestations of multicentric CD. 50 This retrospective study of the medical records of 10 patients with histologically confirmed CD who underwent surgery indicated that localized (unicentric) CD is usually of the hyaline vascular type and can be successfully managed by complete surgical resection regardless of the location of the lesion. Multicentric CD may also be managed by complete resection, and CHOP chemotherapy may be appropriate for patients with severe systemic manifestations of the disease. The long-term effectiveness of surgery to limit recurrence and extend survival in patients with CD requires further investigation in more case series or in clinical trials.
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